Patricia Jakel, RN, MN, AOCN, On Treating Patients with CDK 4/6 Inhibitors
March 15th 2020The clinical nurse specialist was also diagnosed with stage III invasive lobular breast cancer and was treated with CDK 4/6 inhibitors, giving her the unique opportunity to speak to both the patient and clinical perspective.